Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France : The EFFEL Study
Copyright © 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. All rights reserved..
OBJECTIVES: This study aimed to quantify the relative importance of barriers to better secondary prevention of osteoporotic fractures and of care expectations expressed by patients with osteoporotic fractures in France.
METHODS: A qualitative exploration of potential barriers to care and expectations was undertaken through a systematic literature review and in-depth patients interviews. A list of 21 barriers and 21 expectations was identified. These were presented to 324 subjects with osteoporotic fractures, identified in a representative sample of the French population, in the form of best-worst scaling questionnaires. Patients rated the relative importance of the attributes, and arithmetic mean importance scores were calculated and ranked. A Bayesian hierarchical model was also performed to generate a relative importance score. Latent class analysis was performed to identify potential subgroups of patients with different response profiles.
RESULTS: A total of 7 barriers were rated as the most important, relating to awareness of osteoporosis and coordination of care. The highest-ranked barrier, "my fracture is not related to osteoporosis," was significantly more important than all the others (mean importance score 0.45; 95% confidence interval 0.33-0.56). A similar ranking of attributes was obtained with both the arithmetic and the Bayesian approach. For expectations, no clear hierarchy of attributes was identified. Latent class analysis discriminated 3 classes of respondents with significant differences in response profiles (the educated environmentalists, the unaware, and the victims of the system).
CONCLUSIONS: Better quality of care of osteoporosis and effective secondary fracture prevention will require improvements in patient education, training of healthcare professionals, and coordination of care.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research - 25(2022), 4 vom: 01. Apr., Seite 571-581 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Launois, Robert [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 05.04.2022 Date Revised 17.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jval.2021.10.005 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338952020 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338952020 | ||
003 | DE-627 | ||
005 | 20231226001824.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jval.2021.10.005 |2 doi | |
028 | 5 | 2 | |a pubmed24n1129.xml |
035 | |a (DE-627)NLM338952020 | ||
035 | |a (NLM)35365301 | ||
035 | |a (PII)S1098-3015(21)01788-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Launois, Robert |e verfasserin |4 aut | |
245 | 1 | 0 | |a Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France |b The EFFEL Study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2022 | ||
500 | |a Date Revised 17.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVES: This study aimed to quantify the relative importance of barriers to better secondary prevention of osteoporotic fractures and of care expectations expressed by patients with osteoporotic fractures in France | ||
520 | |a METHODS: A qualitative exploration of potential barriers to care and expectations was undertaken through a systematic literature review and in-depth patients interviews. A list of 21 barriers and 21 expectations was identified. These were presented to 324 subjects with osteoporotic fractures, identified in a representative sample of the French population, in the form of best-worst scaling questionnaires. Patients rated the relative importance of the attributes, and arithmetic mean importance scores were calculated and ranked. A Bayesian hierarchical model was also performed to generate a relative importance score. Latent class analysis was performed to identify potential subgroups of patients with different response profiles | ||
520 | |a RESULTS: A total of 7 barriers were rated as the most important, relating to awareness of osteoporosis and coordination of care. The highest-ranked barrier, "my fracture is not related to osteoporosis," was significantly more important than all the others (mean importance score 0.45; 95% confidence interval 0.33-0.56). A similar ranking of attributes was obtained with both the arithmetic and the Bayesian approach. For expectations, no clear hierarchy of attributes was identified. Latent class analysis discriminated 3 classes of respondents with significant differences in response profiles (the educated environmentalists, the unaware, and the victims of the system) | ||
520 | |a CONCLUSIONS: Better quality of care of osteoporosis and effective secondary fracture prevention will require improvements in patient education, training of healthcare professionals, and coordination of care | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a attribute identification | |
650 | 4 | |a best-worst scaling | |
650 | 4 | |a fracture | |
650 | 4 | |a latent classes analysis | |
650 | 4 | |a osteoporosis | |
650 | 4 | |a preference elicitation methods | |
650 | 4 | |a secondary prevention | |
700 | 1 | |a Cabout, Elise |e verfasserin |4 aut | |
700 | 1 | |a Benamouzig, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Velpry, Livia |e verfasserin |4 aut | |
700 | 1 | |a Briot, Karine |e verfasserin |4 aut | |
700 | 1 | |a Alliot, Françoise |e verfasserin |4 aut | |
700 | 1 | |a Perrin, Laure |e verfasserin |4 aut | |
700 | 1 | |a Grange, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Sellami, Rahma |e verfasserin |4 aut | |
700 | 1 | |a Touboul, Chantal |e verfasserin |4 aut | |
700 | 1 | |a Joubert, Jean-Michel |e verfasserin |4 aut | |
700 | 1 | |a Roux, Christian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research |d 1998 |g 25(2022), 4 vom: 01. Apr., Seite 571-581 |w (DE-627)NLM115934545 |x 1524-4733 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2022 |g number:4 |g day:01 |g month:04 |g pages:571-581 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jval.2021.10.005 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2022 |e 4 |b 01 |c 04 |h 571-581 |